Brightsurf Science News & Current Events

March 13, 2011
With new method, CSHL team is able to infer how tumors evolve and spread
A new method of analyzing cancerous tumors developed by scientists at Cold Spring Harbor Laboratory (CSHL) suggests that tumors may not evolve gradually, but rather in punctuated or staccato-like bursts.

Miniature 'wearable' PET scanner ready for use
Scientists have demonstrated the efficacy of a

'Good cholesterol' structure identified, could help explain protective effects
University of Cincinnati researchers have determined the structure of human HDL cholesterol and say the finding could help explain how this

'Pre-baby blues' due to lack of support from partner
Pregnancy is meant to be a joyous time however some women experience overwhelming

Untapped crop data from Africa predicts corn peril if temperatures rise
A team led by a Stanford researcher has found a valuable, untapped resource in historical data from crop yield trials conducted across sub-Saharan Africa.

Lancet publishes abstracts for first global health metrics and evaluation conference
The Institute for Health Metrics and Evaluation, the Lancet, Harvard School of Public Health, London School of Hygiene and Tropical Medicine, and the University of Queensland School of Population Health are hosting a conference to advance the field of health metrics and evaluation.

Berkeley Lab scientists achieve breakthrough in nanocomposite for high-capacity hydrogen storage
Berkeley Lab researchers have designed a new composite material for hydrogen storage consisting of nanoparticles of magnesium metal sprinkled through a polymer related to Plexiglas that rapidly absorbs and releases hydrogen at modest temperatures without oxidizing the metal after cycling.

Consortium finds chronic liver cirrhosis clues
Researchers have provided new clues to the genetic causes of primary biliary cirrhosis -- a chronic form of liver disease, which leads to transplant surgery for the majority of patients.

Combination overcomes breast cancer resistance to herceptin
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at the University of Texas MD Anderson Cancer Center report online at Nature Medicine. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to